Anaphylaxis

Book ChapterAçık Erişim

Özet

Anaphylaxis is a life-threatening systemic hypersensitivity reaction that usually develops within one to two hours after exposure to an allergen. The most common symptoms of anaphylaxis are shortness of breath, urticarial rash, and swelling of the mucosa. In one-fifth of the cases, the cause of anaphylaxis cannot be found, but it is mostly due to drug intake, insect bites, and foods. Serious anaphylactoid reactions, which can be fatal, may occur in patients with asthma, advanced age, cardiovascular disease, mast cell disorders, and allergic reactions due to drug intake. Recognition of anaphylaxis and prompt initiation of treatment are of critical importance. In the acute treatment of anaphylaxis, intramuscular epinephrine is administered first, and airway, respiratory, and circulatory support is provided. The patient is observed for up to 4-12 hours for biphasic reactions that may develop afterwards. After an anaphylactic reaction, an emergency action plan should be developed for the patient. The patient should be directed to an allergist, and the patient should be educated about the elimination of the allergic agent and the use of an epinephrine auto-injector. The quality of the acute and long-term management of anaphylaxis is effective in whether patients experience good or bad outcomes. © 2024 Nova Science Publishers, Inc. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11854Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTanriverdi, Orhan
dc.date.accessioned2026-10-18T20:26:50.906135654Z
dc.date.available2026-10-18T20:26:50.906135654Z
dc.date.issued2024
dc.description.abstractAnaphylaxis is a life-threatening systemic hypersensitivity reaction that usually develops within one to two hours after exposure to an allergen. The most common symptoms of anaphylaxis are shortness of breath, urticarial rash, and swelling of the mucosa. In one-fifth of the cases, the cause of anaphylaxis cannot be found, but it is mostly due to drug intake, insect bites, and foods. Serious anaphylactoid reactions, which can be fatal, may occur in patients with asthma, advanced age, cardiovascular disease, mast cell disorders, and allergic reactions due to drug intake. Recognition of anaphylaxis and prompt initiation of treatment are of critical importance. In the acute treatment of anaphylaxis, intramuscular epinephrine is administered first, and airway, respiratory, and circulatory support is provided. The patient is observed for up to 4-12 hours for biphasic reactions that may develop afterwards. After an anaphylactic reaction, an emergency action plan should be developed for the patient. The patient should be directed to an allergist, and the patient should be educated about the elimination of the allergic agent and the use of an epinephrine auto-injector. The quality of the acute and long-term management of anaphylaxis is effective in whether patients experience good or bad outcomes. © 2024 Nova Science Publishers, Inc. All rights reserved.
dc.identifier.endpage208
dc.identifier.isbn979-889113728-8; 979-889113624-3
dc.identifier.scopus2-s2.0-85196960615
dc.identifier.startpage191
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11854
dc.language.isoen
dc.publisherNova Science Publishers, Inc.
dc.relation.ispartofCurrent Approaches to Allergic Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAllergy
dc.subjectAnaphylaxis
dc.subjectAngioneurotic edema
dc.subjectUrticaria
dc.titleAnaphylaxis
dc.typeBook Chapter
dspace.entity.typePublication
rdl.citation.scopus0
rdl.source.indexSCOPUS